Related Experiment Videos
[Modern antimycotic therapy in obstetrics]
Akusherstvo I Ginekologiia
|January 1, 1993
Summary
Local treatment with Gyno-Pevaril effectively cured over 80% of pregnant women with colpitis mycotica in the first course. This antimycotic treatment demonstrated high safety and efficacy during pregnancy.
Area of Science:
- Obstetrics and Gynecology
- Medical Mycology
Context:
- Colpitis mycotica (vaginal yeast infection) is common in pregnant women.
- Treatment options must be safe for both mother and fetus.
Purpose:
- To evaluate the efficacy and safety of topical Gyno-Pevaril for treating colpitis mycotica in pregnant women.
Summary:
- A study of 40 pregnant women with confirmed colpitis mycotica used local antimycotic treatment with Gyno-Pevaril.
- An 82% cure rate was achieved in the first treatment course, with 15% cured after a second course.
- A 3% success rate was observed after a third course for mixed flora, indicating high overall treatment effectiveness.
Impact:
- Gyno-Pevaril offers a safe and effective local treatment for vaginal yeast infections during pregnancy.
- The study supports the use of Gyno-Pevaril for managing colpitis mycotica in obstetric patients.